(Press-News.org)
When the new SARS-CoV-2 virus began killing thousands of people every week, physicians and scientists around the globe raced to learn why the new pathogen was so deadly. Among many early findings, experts noted that the infection played havoc with blood circulation, both inflaming the linings of blood vessels and making the blood itself more likely to form dangerous clots.
Critically ill COVID-19 patients suffered pulmonary embolisms, deep vein thrombosis (DVT), arterial thrombosis, as well as microvascular thrombosis affecting tissues of the lungs, kidneys, and heart.
Doctors tried a wide array of existing medications in hopes of controlling the blood system impacts, with mixed results at best. Especially early on, care teams were flying blind. Vital information about the cellular mechanisms affected by the virus remained largely unknown.
Frustrating the search for effective treatments, the traditional research approach based on studying data from mouse models was not generating useful answers. Mice simply do not experience infections from this virus the same ways people do. Nor do other rodents.
Enter the emerging field of organoid medicine.
Lab-grown human tissues demonstrate value
In the past two decades, scientists have made impressive strides at coaxing human stem cells to form tiny-but-functional versions of human organs. Cincinnati Children’s has been a leader in this field, with groundbreaking developments of tissues that mimic the functions of the intestine, stomach, esophagus and more.
Now, an expert at Cincinnati Children’s working with a team of colleagues in Japan has applied organoid technology to make a significant discovery in the race to develop effective COVID treatments. Their findings were published online Oct. 5, 2023, in the journal Cell Stem Cell.
“We developed a human vascular organoid model that accurately mimics the damage caused by SARS-CoV-2,” says the study’s corresponding author Takanori Takebe, M.D., Ph.D. “After conducting many proteomic, genetic and other studies, we determined that the severe vascular damage and thrombosis associated with COVID-19 can be mitigated by a long-acting monoclonal antibody that targets the complement amplification cycle regulated by factor D (CFD).”
Takebe is an expert in organoid medicine who holds dual appointments with Cincinnati Children’s and Tokyo Medical and Dental University. He also serves as director for commercial innovation at Cincinnati Children’s Center for Stem Cell and Organoid Research and Medicine (CuSTOM).
Co-first authors of the study were Eri Kawakami, Ph.D., with the Takeda Pharmaceutical Company, and Norikazu Saiki, Ph.D., at Tokyo Medical and Dental University.
Next steps: build on modest initial benefits
In addition to the organoid tissue findings, the research team confirmed many of their observations with testing involving macaque monkeys. All of the primate studies were conducted in Japan.
The team reports, however, that the particular monoclonal antibody used in the study resulted in only modest reductions in inflammation. Next steps include further testing involving “humanized” animal models to accurately assess the impact of a clinical-grade CFD targeted antibody, Takebe says.
About this study
This research was partly funded by Takeda Pharmaceuticals. Takebe also holds a patent associated with the technology described in this project.
Funding sources also included the Japan Agency for Medical Research and Development (JP21bm0404045, JP20fk0108280, 20fk0108404, 23gm1610005, 23gm1210012, 19fk0108172, 20fk0108410, 20fk0108538, and 223fa627008, JSPS 18H02800, 19K22416); JST Moonshot R&D grants (JPMJPS2033, JPMJMS2022); a Cincinnati Children’s Research Foundation CURE award; the National Institute of Health’s New Innovator Award (DP2 DK128799-01); the Falk Transformational Awards Program; and the World Premier International Research Center Initiative (WPI), MEXT, Japan.
Read the findings in Cell Stem Cell
Learn more about organoid research at Cincinnati Children’s
Novel Approach Generates Most Complex Stomach, Esophagus Organoids to Date
A New First: Creating Organoids with Immune Systems
World’s First Three-Organoid System Opens Doors for Medical Research and Diagnosis END
New research has shed light on how genetics influences the growth of the placenta, revealing a link to risk of disease in the mother.
Scientists from the University of Exeter worked with colleagues in Norway and Denmark to lead a largescale international collaboration which examined placental growth in the greatest detail yet. They caried out the first ever genome-wide association study of the weight of the placenta at birth, generating a number of revelations. Among the findings published in Nature Genetics, the team concluded that faster growth of the placenta can contribute to risk of preeclampsia, and to earlier delivery ...
Creating artificial life is a recurring theme in both science and popular literature, where it conjures images of creeping slime creatures with malevolent intentions or super-cute designer pets. At the same time, the question arises: What role should artificial life play in our environment here on Earth, where all life forms are created by nature and have their own place and purpose?
Associate professor Chenguang Lou from the Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, together with Professor Hanbin Mao from Kent State University, is the parent of a special artificial hybrid molecule that could lead to ...
Scientists using the H.E.S.S. observatory in Namibia have detected the highest energy gamma rays ever from a dead star called a pulsar. The energy of these gamma rays clocked in at 20 tera-electronvolts, or about ten trillion times the energy of visible light. This observation is hard to reconcile with the theory of the production of such pulsed gamma rays, as the international team reports in the journal Nature Astronomy.
Pulsars are the left-over corpses of stars that spectacularly exploded in a supernova. The explosions leave behind ...
A team of scientists at the QOT Centre for Quantum Optical Technologies, including a student from the Faculty of Physics (University of Warsaw), made a device capable of the conversion of quantum information between microwave and optical photons. The results of research, published in “Nature Photonics” magazine, highlight a new microwave detection method with possible applications in quantum technologies, as a part of quantum network infrastructure, and in microwave radio-astronomy.
Conversion of quantum information
Whenever you listen to a song on your phone or computer, a conversion of information happens – ...
About The Study: This study found that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease. Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes.
Authors: Mahyar Etminan, Pharm.D., M.Sc., of the University of British Columbia in Vancouver, is the corresponding author.
To access the embargoed study: Visit ...
For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomised trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October).
Despite better systems for monitoring blood sugars and delivering insulin, hormonal changes and altered eating patterns during pregnancy mean that ...
A research team co-led by scholars from City University of Hong Kong (CityU) has successfully morphed all-inorganic perovskites at room temperature without compromising their functional properties. Their findings demonstrate the potential of this class of semiconductors for manufacturing next-generation deformable electronics and energy systems in the future.
All-inorganic lead halide perovskites are becoming increasingly important semiconducting materials in energy conversion and optoelectronics because of their outstanding performance and enhanced environmental stability.
“However, unlike metal ...
HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the launch of Texas Health Equity Alliance for Breast Cancer (THEAL), a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women.
THEAL builds upon the expertise of MD Anderson’s Department of Health Disparities Research in addressing the determinants of cancer disparities while leveraging the cancer prevention and control platform’s experience in leading cross-sector collaboratives ...
“The Queen’s Gambit” miniseries portrayed the life of a fictional chess prodigy, Beth Harmon, who is continuously underestimated in male-dominated competitions. A team of New York University psychology researchers has now found some “real-life” evidence of what Harmon faced as a younger player: Parents and coaches of youth chess players peg the highest potential rating of girl players to be lower than that of boy players.
Moreover, the study’s authors, who included Jennifer Shahade, a two-time US Women’s Chess champion, found ...
Young female chess players often face gender bias both in the male-dominated chess world and among parents and mentors who believe girls have less potential to succeed in chess than boys, according to research published by the American Psychological Association.
“It’s disheartening to see young female players’ potential downgraded, even by the people who are closest to them, like their parents and coaches,” said lead researcher Sophie Arnold, a doctoral student at New York University.
The study, which was published online in the Journal of Experimental Psychology: General, presents what the researchers say is the first large-scale ...
